Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

protein kinase inhibitors as Targeted therapy for glioblastoma: A meta-analysis of randomized controlled clinical trials.

Autor: Pinto-Fraga J; i+HeALTH Strategic Research Group, Miguel de Cervantes European University, 27038 Valladolid, Spain., García-Chico C; i+HeALTH Strategic Research Group, Miguel de Cervantes European University, 27038 Valladolid, Spain., Lista S; i+HeALTH Strategic Research Group, Miguel de Cervantes European University, 27038 Valladolid, Spain., Lacal PM; Laboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy., Carpenzano G; Department of Neurosurgery, Policlinico Tor Vergata, University of Rome Tor Vergata. Rome, Italy., Salvati M; Department of Neurosurgery, Policlinico Tor Vergata, University of Rome Tor Vergata. Rome, Italy., Santos-Lozano A; i+HeALTH Strategic Research Group, Miguel de Cervantes European University, 27038 Valladolid, Spain; Research Institute of the Hospital 12 de Octubre ('Imas12' [PaHerg Group]), 28041 Madrid, Spain., Graziani G; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address: graziani@uniroma2.it., Ceci C; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Publikováno v: Pharmacological research [Pharmacol Res] 2024 Dec 03, pp. 107528. Date of Electronic Publication: 2024 Dec 03.